
Asked Questions
Where Can I Go To Provide A Sample For Testing?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit.
What happens to my sample once I have provided it?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
What will laboratory testing cost me?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Using Innovative Technology
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Our Client Happy Say About Us



There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in someform, by injected humour, or randomised words which don’t look even believable.There are many variations of passages of It is a long established fact that a reader will be distracted
Dr. john Martin
Cancer Research
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in someform, by injected humour, or randomised words which don’t look even believable.There are many variations of passages of It is a long established fact that a reader will be distracted
Dr. john Martin
Cancer Research
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in someform, by injected humour, or randomised words which don’t look even believable.There are many variations of passages of It is a long established fact that a reader will be distracted
Dr. john Martin
Cancer Research

See Our Latest Blog
- S V Healthcare
- 0 Comments
AstraZeneca Launches Eculizumab in India: A Breakthrough for Rare Disease Treatment
AstraZeneca’s recent announcement of the launch of eculizumab in India marks a significant milestone in the treatment of rare diseases. For patients suffering from ultra-rare, life-threatening disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), this launch brings hope to the Indian medical community for access to long-awaited therapies. Regulatory Approval […]
- S V Healthcare
- 0 Comments
How to Reduce Your Risk of Heart Attack Naturally | Best Heart Health Tips
Learn how to reduce the risk of heart attack naturally with the best heart health tips. Simple changes in lifestyle, diet and habits can protect your heart.
- S V Healthcare
- 0 Comments
The Role of Personalized Medicine in Modern Healthcare
Learn how personalized medicine is transforming healthcare with tailored treatments, better outcomes and innovative solutions from S V Healthcare.
- S V Healthcare
- 0 Comments
Top Emerging Markets for Pharma Exports in 2025
S V Healthcare is expanding into emerging pharma markets in 2025. Discover key opportunities, challenges, and strategies for success.
- S V Healthcare
- 0 Comments
Biocon Biologics Gains UK Market Entry for Denosumab Biosimilars Vevzuo & Evfraxy
Biocon Biologics has received UK MHRA approval for denosumab biosimilars Vevzuo and Avefraxi, expanding its global biosimilar footprint in 2025.
- S V Healthcare
- 0 Comments
India’s Pharma Exports Surge 9%, Beating Global Growth Rate: Report
India’s pharma exports grew by 9% in FY 2024-25, higher than the global average. Find out the key drivers, trends and future outlook in this pharma export report.
- S V Healthcare
- 0 Comments
How Could Tariff Impact on Pharma Industry Globally?
Discover how tariffs impact the pharma industry globally. Learn about global trade challenges and how S V Healthcare adapts to changing export scenarios.
- S V Healthcare
- 0 Comments
India’s Nutraceutical Boom: Why 2025 Is a Pivotal Year for Pharma Exporters
India’s nutraceutical market is on the verge of a big leap, expected to reach US$18 billion by 2025. For pharma exporters, this is not just a figure, it’s a signal to take action. As health-conscious consumers drive demand for food supplements and functional wellness products, companies like S V Healthcare, India’s best pharmaceutical company, are […]
- S V Healthcare
- 0 Comments
The New Leap of Indian Pharma Export in 2025
Learn how India’s pharma exports, led by companies like SV Healthcare, are set to revolutionise global healthcare in 2025 with innovation and growth.
frequently asked questions
We focus on best quality, diverse product range and extensive experience in global exports. Our commitment to innovation, patient welfare and international health sets us apart.
We offer a comprehensive portfolio covering pharmaceutical, nutraceutical and cosmetics categories- e.g., Neproxen Tablets, Pantoprazole for injection, Melatonin Tablets, Fish Oil Softgel Capsule, Joint Support Tablets, VR Vitamin C Serum, VR Hair Growth Serum, etc.
We have a strong presence in various markets across the world, including USA, Myanmar, Cambodia, Venezuela, South East Asia, Latin America markets etc.
Our team has extensive experience navigating international regulations, customs clearance, and logistics, ensuring smooth delivery around the world.
We provide comprehensive support throughout the export process, including regulatory guidance, logistics coordination, and documentation assistance.
To export pharmaceuticals from India, you need to obtain the following licenses:
- Import Export Code (IEC) from Directorate General of Foreign Trade (DGFT)
- Bulk Drug License from State Drug Controller
- Good Manufacturing Practice (GMP) certification from World Health Organization (WHO) or National Regulatory Authority
- Free Sale Certificate from Central Drugs Standard Control Organization (CDSCO)
India exports a wide range of medicines, but the most commonly exported medicines include:
- Antiretroviral drugs (ARVs) for the treatment of HIV/AIDS
- Vaccines (e.g., measles, DTP and BCG)
- Antibiotics (e.g., amoxicillin and ciprofloxacin)
- Pain relievers (e.g., paracetamol and ibuprofen)
- Anti-inflammatory drugs (e.g., diclofenac and aceclofenac)
If you meet the regulatory requirements and obtain the necessary licenses, you can export pharma products from India. You must follow the guidelines set by CDSCO, DGFT and other relevant authorities.
You can find buyers for pharmaceutical exports from India through the following:
- Trade fairs and exhibitions
- Online marketplaces (e.g., Alibaba, Thomasnet)
- Industry associations (e.g., Indian Pharmaceutical Alliance, Pharmexcil)
- Personal networks and word-of-mouth referrals
- Websites of regulatory authorities (e.g., CDSCO, DGFT)
India exports medicines to over 200 countries, but the top importers include:
- United States
- United Kingdom
- Germany
- South Africa
- Brazil
- Russia
India ranks third in terms of pharmaceutical exports in the world, after the United States and China. (Source: Pharmexcil, 2022)
To export nutraceuticals from India:
- Obtain the required licenses (e.g., IEC, FSSAI registration)
- Comply with regulatory requirements (e.g., GMP, labeling)
- Meet the standards of the importing country
- Partner with a reputed freight forwarder or export house
The Indian nutraceutical market was valued at around ₹30,000 crore (USD 4 billion) in 2022 and is expected to grow at a CAGR of 15% by 2025. (Source: ASSOCHAM, 2022)
The most popular nutraceuticals in India include:
- Vitamin and mineral supplements
- Protein powders and bars
- Probiotics
- Omega-3 fatty acids
- Ayurvedic and herbal supplements (e.g., ashwagandha, turmeric)